Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis.
Holroyd CR, Seth R, Bukhari M, Malaviya A, Holmes C, Curtis E, Chan C, Yusuf MA, Litwic A, Smolen S, Topliffe J, Bennett S, Humphreys J, Green M, Ledingham J. Holroyd CR, et al. Among authors: ledingham j. Rheumatology (Oxford). 2019 Feb 1;58(2):e3-e42. doi: 10.1093/rheumatology/key208. Rheumatology (Oxford). 2019. PMID: 30137552 No abstract available.
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
Deighton C, Hyrich K, Ding T, Ledingham J, Lunt M, Luqmani R, Kiely P, Bukhari M, Abernethy R, Ostor A, Bosworth A, Gadsby K, McKenna F, Finney D, Dixey J; on behalf of BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR. Deighton C, et al. Among authors: ledingham j. Rheumatology (Oxford). 2010 Mar 22. doi: 10.1093/rheumatology/keq006b. Online ahead of print. Rheumatology (Oxford). 2010. PMID: 20308120 No abstract available.
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
Deighton C, Hyrich K, Ding T, Ledingham J, Lunt M, Luqmani R, Kiely P, Bukhari M, Abernethy R, Ostor A, Bosworth A, Gadsby K, McKenna F, Finney D, Dixey J; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR. Deighton C, et al. Among authors: ledingham j. Rheumatology (Oxford). 2010 Jun;49(6):1197-9. doi: 10.1093/rheumatology/keq006a. Epub 2010 Mar 22. Rheumatology (Oxford). 2010. PMID: 20308121 No abstract available.
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
Ding T, Ledingham J, Luqmani R, Westlake S, Hyrich K, Lunt M, Kiely P, Bukhari M, Abernethy R, Bosworth A, Ostor A, Gadsby K, McKenna F, Finney D, Dixey J, Deighton C; Standards, Audit and Guidelines Working Group of BSR Clinical Affairs Committee; BHPR. Ding T, et al. Among authors: ledingham j. Rheumatology (Oxford). 2010 Nov;49(11):2217-9. doi: 10.1093/rheumatology/keq249a. Epub 2010 Sep 12. Rheumatology (Oxford). 2010. PMID: 20837498 No abstract available.
BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.
Bukhari M, Abernethy R, Deighton C, Ding T, Hyrich K, Lunt M, Luqmani R, Kiely P, Bosworth A, Ledingham J, Ostör A, Gadsby K, McKenna F, Finney D, Dixey J; BSR and BHPR Standards, Guidelines and Audit Working Group. Bukhari M, et al. Among authors: ledingham j. Rheumatology (Oxford). 2011 Dec;50(12):2311-3. doi: 10.1093/rheumatology/ker106a. Epub 2011 May 4. Rheumatology (Oxford). 2011. PMID: 21546351 No abstract available.
The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis.
Malaviya AP, Ledingham J, Bloxham J, Bosworth A, Buch M, Choy E, Cope A, Isaacs J, Marshall D, Wright G, Ostör AJ; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group; BHPR. Malaviya AP, et al. Among authors: ledingham j. Rheumatology (Oxford). 2014 Jul;53(7):1344-6. doi: 10.1093/rheumatology/keu168. Epub 2014 May 12. Rheumatology (Oxford). 2014. PMID: 24821853 No abstract available.
BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.
Ledingham J, Gullick N, Irving K, Gorodkin R, Aris M, Burke J, Gordon P, Christidis D, Galloway S, Hayes E, Jeffries A, Mercer S, Mooney J, van Leuven S, Galloway J; BSR and BHPR Standards, Guidelines and Audit Working Group. Ledingham J, et al. Rheumatology (Oxford). 2017 Jun 1;56(6):865-868. doi: 10.1093/rheumatology/kew479. Rheumatology (Oxford). 2017. PMID: 28339817 No abstract available.
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summary.
Holroyd CR, Seth R, Bukhari M, Malaviya A, Holmes C, Curtis E, Chan C, Yusuf MA, Litwic A, Smolen S, Topliffe J, Bennett S, Humphreys J, Green M, Ledingham J. Holroyd CR, et al. Among authors: ledingham j. Rheumatology (Oxford). 2019 Feb 1;58(2):220-226. doi: 10.1093/rheumatology/key207. Rheumatology (Oxford). 2019. PMID: 30137623 No abstract available.
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis.
Holroyd CR, Seth R, Bukhari M, Malaviya A, Holmes C, Curtis E, Chan C, Yusuf MA, Litwic A, Smolen S, Topliffe J, Bennett S, Humphreys J, Green M, Ledingham J. Holroyd CR, et al. Among authors: ledingham j. Rheumatology (Oxford). 2019 Feb 1;58(2):372. doi: 10.1093/rheumatology/key298. Rheumatology (Oxford). 2019. PMID: 30239912 No abstract available.
381 results